TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Intestinal barrier permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of postoperative complications of grade II or higher
Endpoint domain: Adverse events/effects
Primary endpoint: F2-Isop levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BWL at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utility index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of AVR/cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: annualised Vpeak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted NT-proBNP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse cardiovascular events (AVE) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SDMT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: ethical predictability of patient safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death from cardiovascular causes or non-fatal heart failure events
Endpoint domain: Mortality/survival
Primary endpoint: WM capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of SCLR
Endpoint domain: Mortality/survival
Primary endpoint: ΔNB from postabsorptive to postprandial period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: symptoms of social anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low-density lipoprotein cholesterol (LDL cholesterol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: thrombin peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: thrombin inactivation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quality of perinatal care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of suicidal ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants who improved their diet and exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acceptance of mood management resource
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Smoking abstinence at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean placebo-corrected change from baseline QTcF (∆∆QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: global health status QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive attitude toward the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Understanding of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 48-h AUC movement NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated Hemoglobin Loss (HBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Need for Blood Transfusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cmax, AUC0-t, and AUC0-∞ geometric mean ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of recurrent depression
Endpoint domain: Mortality/survival
Primary endpoint: Causal effect of ADHD genetic liability on major depression
Endpoint domain: Mortality/survival
Primary endpoint: ephedrine usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to exhaust
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned hospital readmission
Endpoint domain: Mortality/survival
Primary endpoint: Pain reduction (VAS Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of disability (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capabilities (BPFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fatigue levels of crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of crown fractures
Endpoint domain: Adverse events/effects
Primary endpoint: roughness of infiltrated-enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bacterial counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Median percent reduction in seizure frequency per 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fifty-percent responder rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Seizure-freedom rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Mean calculated LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: additional quality-adjusted life-years (QALYs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incidence of covert brain infarcts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of clinical ischemic strokes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of new microbleeds
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle tension recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion less than grade II of elbow MAS grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brunnstrom stage of arm and hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failure rate for unruptured MCA aneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale score >2 (dependency or death) for ruptured MCA aneurysms
Endpoint domain: Mortality/survival
Primary endpoint: Complete aneurysm occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the program
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Adverse effects (tiredness and lower limb pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Neutralizing antibody responses to live SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in TNF‐α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: food group knowledge
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: liking to eat fruit
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: beliefs about how healthy fruits are
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: non‐taste test fruit preferences
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: liking to eat vegetables
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: beliefs about how healthy vegetables are
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: taste test vegetable preferences
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: quality-adjusted life-year (QALY) gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: TNF-α serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CRP serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean modified MASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: viral suppression rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient attrition from care
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of vessels demonstrating low WSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median circumferential WSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of stented coronary vessel areas exposed to low WSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nontechnical skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Situation awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decision-making
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected final visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in LV end-systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV reverse remodelling responder rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Continuous abstinence during the final 4 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous abstinence at the 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in self-reported smoking rate during the prequit period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serogroup B IMD cases
Endpoint domain: Mortality/survival
Primary endpoint: PRWE (Patient Rated Wrist Evaluation)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Q-DASH (Quick Disabilities of the Arm, Shoulder and Hand)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: COPM (Canadian Occupational Performance Measure) satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of sagittal femoral component angle (sFCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of sagittal tibial component angle (sTCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral infarcts postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brushing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of spinal anesthesia-induced hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Usage of vasopressors (ephedrine)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with EHS > 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with positive GAQ-1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PedsQL (Pediatric Quality of Life Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in attention domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean shear moduli of supraspinatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean GH Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Transient increases in adrenocorticotropic hormone, cortisol, and prolactin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Prolongation of mean QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NRS scores of wound pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total dose of emergency analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean time between first application of analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction of fear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shorter DNT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: length of phrases used to express themselves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conversational turn-taking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of different words spoken
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMA scores before discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time to the first defecation after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: relief of discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TB disease
Endpoint domain: Mortality/survival
Primary endpoint: Progression of baPWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Upper abdominal pain score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smaller LVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FMA-LE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shorter recovery time of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower occurrence of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: higher overall efficiency of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for successful PDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to operability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of proximal colon cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Risk of colorectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ETI time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Optimal glottic views
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: all-cause mortality and reoperation
Endpoint domain: Mortality/survival
Primary endpoint: subjective evaluation score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduced likelihood of at-risk drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer alcohol problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS-pain (Visual Analog Scale for pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body mass (BM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus rhythm at 6 weeks from cardioversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average Surface Distance (ASD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hausdorff Distance (HD95%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of PD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients experiencing desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saturation levels at the end of EBUS procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient discomfort during the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year composite of cardiovascular events or major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improved participant management of PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall patient satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of patients in lupus low disease activity state (LLDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight increase from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adjusted odds of having ACR greater than 30 mg/g
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean urine IL-18 concentration at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of eGFR decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fugl‐Meyer Assessment for upper‐extremity shoulder/elbow/forearm score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-confidence scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Association with PD-L1 IHC assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of PD-L1 expression distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of ICI response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-reactive, multi-functional CD4+ and CD8+ T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Requirement for tracheal intubation or mortality within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of post-neurotomy pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multimorbidity progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of SCC
Endpoint domain: Mortality/survival
Primary endpoint: Post-operative hospital stay time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Speech and swallowing function recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Opioid consumption in MME
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical pain scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first increase in plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hematologic toxicity and oral cavity mucositis (≥grade 2)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with an abnormal Nugent score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate to VNS therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen saturation time below 90% SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knowledge, attitude and behaviour scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ultimate load to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: yield load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: On-demand visits per patient-year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acute outpatient visits per patient-year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Risk of jaundice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of phrenic block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of daily breaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent on short sedentary bouts (<20 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in shortest sedentary bouts (5–10 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-management ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: blood phosphorus levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Impact on lifespan potential
Endpoint domain: Mortality/survival
Primary endpoint: CAD risk association
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of grade 3 or 4 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Daily servings of regular, sugar-sweetened soda
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye Fissure Index (EFI) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Iris Coverage (LIC) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes